Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TEM-1 β-lactamase is a class A serine hydrolase enzyme, most commonly found in Gram-negative bacteria, and responsible for resistance to penicillins and early generation cephalosporins. Engineered versions involve specific mutations, substitutions, or chimeric recombinations to probe enzymatic properties, substrate scope, stability, and inhibitor susceptibility. Its catalytic mechanism involves a nucleophilic serine attacking the β-lactam ring of antibiotics, facilitating hydrolysis and drug inactivation[1][2][3][4][5][6]. Engineered mutants are also critical for studying the molecular evolution and biophysical characterization of β-lactamase function, as well as developing new antibacterial strategies. The clinical significance of TEM-1 and its derivatives rests in their roles in multidrug-resistant infections, which continue to drive the need for novel therapies and diagnostic monitoring.
Hydrolysis of the β-lactam ring of antibiotics, leading to inactivation of the antimicrobial agent and ensuing resistance[1][2][3][4][5]. Mutations and engineered alterations can extend substrate specificity or confer resistance to β-lactamase inhibitors[2][4][5].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEM-1 β-lactamase (TEM-1).